Introduction
Localising the source for Cushing's syndrome can be a challenge, when the investigations being performed are limited in its sensitivities and specificities. This case report explores these challenges with investigating a patient with clinical and biochemical features of Cushing's syndrome.
Case

Results
Conclusion
The limitations in investigations for Cushing's syndrome should be taken into account when investigating patients for this condition. We recommend that when biochemical testing becomes inconclusive, it should prompt further investigations such as MRI Pituitary and Inferior petrosal sinus sampling to rule out a pituitary source. Additionally, specialist radiological modalities such as NM Ga68 DOTANAC scanning should be sought to identify the causative lesion, especially when ectopic sources are suspected. 6) Inferior petrosal sinus sampling: no difference between the ratios on both sides of the inferior petrosal sinus and peripheral samples, excluding a pituitary source for excessive ACTH production. On physical examination, she had telangiectasia across both cheeks, pink striae across her abdomen and flanks with proximal muscle wasting. Her blood pressure was 215/112mmHg. A differential diagnosis of Cushing's syndrome was suspected. Her HbA1c was 41mmol/l. Radiologist re-review NM Ga68 DOTANAC scan :small focus of trace activity posterior to a 7mm nodule in the left lung base which revealed some mild somatostatin receptor positivity. Corresponded to lesion on Thoracic MRI. Inter and intra-observer variability in identifying such a small lesion.
9) Further MRI NM MIBG Iodine 123
No increase in tracer activity in small pulmonary nodule. 10) NM Whole Body FDG PET CT: 1.2 cm X 1.1 cm nodule within left lower lobedemonstrating low activity.
She went on to have a Video Assisted Thoracoscopy assisted left lower lobectomy and this was identified as a 11mm nodule, cream-coloured on histology.
This was classified as a typical ACTHproducing carcinoid tumour which was staged as T1a N0 M0.
Discussion
Ectopic ACTH production accounted for 10-15% of Cushing's syndrome and Ectopic CRH secretion for less than 1% 1 . In the group of ectopic ACTH, only about 1-5% of Bronchial Neuroendocrine tumours were associated with ectopic ACTH secretion 2,3 .
The use of the High dose dexamethasone suppression test was found to be limited as with this case, as noted in a case series that up to 83% of ectopic ACTH producing bronchial tumours demonstrated suppression on HDDST, making the diagnosis very difficult 4 . Additionally, it was noted that with the size of these carcinoid tumours, they can also easily elude imaging on CT Chest 5 . Thus, we recommend the use of functional imaging such as the DOTANAC scans for further correlation, together with Inferior Petrosal Sinus sampling to differentiate between a pituitary and an ectopic source of Cushing's syndrome in indeterminate cases of elevated ACTH levels. 
